NVCS for Medication Management

To assess the use of and persistence to ACE inhibitors or Angiotensin receptor blockers (ARB) among members with CAD or other atherosclerotic vascular disease (i.e., peripheral arterial disease, atherosclerotic aortic disease and carotid artery disease) who are at high risk for coronary events during a one year period. High-risk comorbidities are defined as heart failure, hypertension, diabetes, or chronic kidney disease (excluding stage V and patients on dialysis).

Medication Possession Ratio (MPR) for statin therapy in diabetic individuals over 18 years of age

Assess the use of and the adherence of antipsychotics among members with schizophrenia during the measurement year